Kienbock disease
Conditions
Interventions
None listed
Sponsors
Yuki HARA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: kienbokk disease patients who undergo BMC transplantation
Exclusion criteria
Exclusion criteria: not agree
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cell count of inspirated BMB colony forming unit number after cell culture, CD34 count, Clinical outcome | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical outcome | — |
Countries
Japan
Outcome results
None listed